Price cuts for this class of drugs would generally be welcome news, as GLP-1 medications are highly effective at promoting weight loss and improving cardiometabolic health, as well as preventing diabetes and heart, kidney disease and liver disease
however, levels declined close to baseline by month 18
And if you're not in a trial, you have a 0% chance. Challenges remain in getting regulatory approval for adjunctive therapies in type 1 diabetes namely, ensuring there are financial incentives for drug makers to run large scale trials that can be submitted to the FDA for approval
They genuinely take the time to listen to your concerns and provide thoughtful feedback, without any pressure to undergo treatments you aren't sure about
One long-term study followed over 22,000 participants in Greece and ranked their adherence to the Mediterranean diet on a scale of 0 to 10